Regenerative Medicine News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–3 of 3 articles
Earlier
Critical impact NewsMay 1, 2026
Theradaptive Receives FDA Approval for Pivotal Phase 3 Trial of OsteoAdapt SP in Spinal Fusion
FDA · 2 min
James Chen, PharmDHigh impact NewsApr 29, 2026
Orca Bio's Orca-Q Receives FDA RMAT Designation for High-Risk Blood Cancers Treatment
FDA · 2 min
Dr. Laura BennettHigh impact NewsApr 18, 2026
UCB Acquires Neurona Therapeutics for NRTX-1001 Epilepsy Cell Therapy in $XXX Million Deal
Epilepsy · 3 min
Dr. Sarah MitchellExplore intelligence